La catena delle opzioni mostra i dati chiave delle opzioni azionarie di Cannara Biotech a vari prezzi di esercizio e date di scadenza. I trader utilizzano queste informazioni per analizzare potenziali operazioni e valutare il sentiment del mercato per Cannara Biotech..

Cannara Biotech (OTC:LOVFF) Azioni, Catena delle Opzioni

Cannara Biotech Inc is a vertically integrated producer of premium-grade cannabis and cannabis-derivative products for Canadian markets. The company owns two mega Quebec-based facilities. The company operates in in two segments; Indoor cannabis operations segment which includes the cultivation, processing and sale of dried cannabis and cannabis derivatives for the Canadian market and the Real estate operations segment related to the Farnham and Valleyfield building. Majority of the revenue for the company is generated from its Cannabis operations segment. .

CANNARA BIOTECH INC by Cannara Biotech Inc.

Cannara Biotech Inc

WIIM

OMGA

Omega Therapeutics shares are trading lower after the company reported worse-than-expected Q3 EPS results and Piper Sandler cut its price target on the stock from $9 to $4.

ALUR

Allurion Technologies shares are trading lower after Chardan Capital downgraded the stock from Buy to Neutral.

<p>BMO Capital  analyst Ben Pham   maintains Boralex (TSX:<a class="ticker" href="https://www.benzinga.com/stock/BLX#TSX">BLX</a>) with a Outperform and lowers the price target from C$46 to C$45.</p>


News

Price Target

Analyst Ratings

TSX:BLX

BMO Capital Maintains Outperform on Boralex, Lowers Price Target to C$45

VUZI

Vuzix shares are trading lower after the company reported worse-than-expected Q3 financial results.

<p>Deep-pocketed investors have adopted a bearish approach towards Tempus AI (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TEM#NASDAQ">TEM</a>), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in TEM usually suggests something big is about to happen.</p>
<p>We gleaned this information from our observations today when Benzinga's options scanner highlighted 8 extraordinary options activities for Tempus AI. This level of activity is out of the ordinary.</p>
<p>The general mood among these heavyweight investors is divided, with 37% leaning bullish and 50% bearish. Among these notable options, 6 are puts, totaling $683,586, and 2 are calls, amounting to $99,000.</p>
<h3>What's The Price Target?</h3>
<p>Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $30.0 to $55.0 for Tempus AI during the past quarter. </p>
<h3>Insights into Volume &amp; Open Interest</h3>
<p>Looking at the volume and open interest is an insightful way to conduct due diligence on a stock.</p>
<p>This data can help you track the liquidity and interest for Tempus AI's options for a given strike price.</p>
<p>Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Tempus AI's whale activity within a strike price range from $30.0 to $55.0 in the last 30 days. </p>
<h3>Tempus AI 30-Day Option Volume &amp; Interest Snapshot</h3>
<p><img src="https://www.benzinga.com/files/images/story/2024/1731687434_0.png" alt="Options Call Chart" /></p>
<h3>Biggest Options Spotted:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th align="right"><strong>Open Interest</strong></th>
<th align="right"><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>TEM</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/17/25</td>
<td>$5.8</td>
<td>$4.5</td>
<td>$5.4</td>
<td>$45.00</td>
<td>$246.2K</td>
<td align="right">85</td>
<td align="right">500</td>
</tr>
<tr>
<td>TEM</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/17/25</td>
<td>$6.3</td>
<td>$5.0</td>
<td>$5.4</td>
<td>$45.00</td>
<td>$225.7K</td>
<td align="right">85</td>
<td align="right">462</td>
</tr>
<tr>
<td>TEM</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>11/29/24</td>
<td>$4.7</td>
<td>$4.3</td>
<td>$4.7</td>
<td>$52.00</td>
<td>$92.5K</td>
<td align="right">206</td>
<td align="right">200</td>
</tr>
<tr>
<td>TEM</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>12/13/24</td>
<td>$9.2</td>
<td>$7.7</td>
<td>$9.2</td>
<td>$55.00</td>
<td>$63.4K</td>
<td align="right">10</td>
<td align="right">90</td>
</tr>
<tr>
<td>TEM</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>11/22/24</td>
<td>$23.7</td>
<td>$22.0</td>
<td>$23.0</td>
<td>$30.00</td>
<td>$50.6K</td>
<td align="right">0</td>
<td align="right">44</td>
</tr>
</tbody>
</table>
</p>
<h3>About Tempus AI</h3>
<p>Tempus AI Inc is a technology company. It has built the Tempus Platform, which comprises both a technology platform to free healthcare data from silos and an operating system to make the resulting data useful. Its Intelligent Diagnostics use AI, including generative AI, to make laboratory tests more accurate, tailored, and personal.</p>
<p>After a thorough review of the options trading surrounding Tempus AI, we move to examine the company in more detail. This includes an assessment of its current market status and performance.</p>
<h3>Current Position of Tempus AI</h3>
<ul>
<li>With a trading volume of 572,433, the price of TEM is up by 0.32%, reaching $56.81.</li>
<li>Current RSI values indicate that the stock is may be approaching overbought.</li>
<li>Next earnings report is scheduled for 94 days from now.</li>
</ul>
<h3>What Analysts Are Saying About Tempus AI</h3>
<p>2 market experts have recently issued ratings for this stock, with a consensus target price of $67.5.</p>
<p><strong>Unusual Options Activity Detected: Smart Money on the Move</strong></p>
<p>Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;utm_source=benzinga-insights"><strong>Click here for access</strong></a>.<br />
&#x2A; Reflecting concerns, an analyst from Piper Sandler lowers its rating to Neutral with a new price target of $70.<br />
&#x2A; Reflecting concerns, an analyst from Stifel lowers its rating to Hold with a new price target of $65.</p>
<p>Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Tempus AI with <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> for real-time alerts.</p>


Options

Markets

Behind the Scenes of Tempus AI's Latest Options Trends

<p>Deep-pocketed investors have adopted a bearish approach towards Trade Desk (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TTD#NASDAQ">TTD</a>), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in TTD usually suggests something big is about to happen.</p>
<p>We gleaned this information from our observations today when Benzinga's options scanner highlighted 21 extraordinary options activities for Trade Desk. This level of activity is out of the ordinary.</p>
<p>The general mood among these heavyweight investors is divided, with 19% leaning bullish and 71% bearish. Among these notable options, 11 are puts, totaling $1,047,442, and 10 are calls, amounting to $2,142,826.</p>
<h3>Predicted Price Range</h3>
<p>Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $90.0 to $140.0 for Trade Desk during the past quarter. </p>
<h3>Insights into Volume &amp; Open Interest</h3>
<p>Examining the volume and open interest provides crucial insights into stock research. This information is key in gauging liquidity and interest levels for Trade Desk's options at certain strike prices. Below, we present a snapshot of the trends in volume and open interest for calls and puts across Trade Desk's significant trades, within a strike price range of $90.0 to $140.0, over the past month.</p>
<h3>Trade Desk Option Activity Analysis: Last 30 Days</h3>
<p><img src="https://www.benzinga.com/files/images/story/2024/1731687428_0.png" alt="Options Call Chart" /></p>
<h3>Noteworthy Options Activity:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th align="right"><strong>Open Interest</strong></th>
<th align="right"><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>TTD</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>03/21/25</td>
<td>$34.85</td>
<td>$34.25</td>
<td>$34.4</td>
<td>$90.00</td>
<td>$1.0M</td>
<td align="right">746</td>
<td align="right">301</td>
</tr>
<tr>
<td>TTD</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>09/19/25</td>
<td>$9.5</td>
<td>$9.45</td>
<td>$9.45</td>
<td>$105.00</td>
<td>$608.5K</td>
<td align="right">16</td>
<td align="right">644</td>
</tr>
<tr>
<td>TTD</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>03/21/25</td>
<td>$32.2</td>
<td>$32.0</td>
<td>$32.0</td>
<td>$92.50</td>
<td>$320.0K</td>
<td align="right">634</td>
<td align="right">100</td>
</tr>
<tr>
<td>TTD</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>03/21/25</td>
<td>$32.8</td>
<td>$31.05</td>
<td>$32.4</td>
<td>$92.50</td>
<td>$181.4K</td>
<td align="right">634</td>
<td align="right">100</td>
</tr>
<tr>
<td>TTD</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/16/26</td>
<td>$27.2</td>
<td>$26.75</td>
<td>$27.09</td>
<td>$115.00</td>
<td>$162.8K</td>
<td align="right">486</td>
<td align="right">60</td>
</tr>
</tbody>
</table>
</p>
<h3>About Trade Desk</h3>
<p>The Trade Desk provides a self-service platform that helps advertisers and ad agencies programmatically find and purchase digital ad inventory (display, video, audio, and social) on different devices like computers, smartphones, and connected TVs. It utilizes data to optimize the performance of ad impressions purchased. The firm's platform is referred to as a demand-side platform in the digital ad industry. The firm generates its revenue from fees based on a percentage of what its clients spend on advertising.</p>
<h3>Where Is Trade Desk Standing Right Now?</h3>
<ul>
<li>With a volume of 1,511,116, the price of TTD is down -1.1% at $124.49. </li>
<li>RSI indicators hint that the underlying stock is currently neutral between overbought and oversold.</li>
<li>Next earnings are expected to be released in 90 days.</li>
</ul>
<h3>Professional Analyst Ratings for Trade Desk</h3>
<p>In the last month, 5 experts released ratings on this stock with an average target price of $109.4.</p>
<p><strong>Unusual Options Activity Detected: Smart Money on the Move</strong></p>
<p>Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;utm_source=benzinga-insights"><strong>Click here for access</strong></a>.<br />
&#x2A; Consistent in their evaluation, an analyst from Truist Securities keeps a Buy rating on Trade Desk with a target price of $135.<br />
&#x2A; An analyst from DA Davidson persists with their Buy rating on Trade Desk, maintaining a target price of $134.<br />
&#x2A; An analyst from New Street Research has revised its rating downward to Sell, adjusting the price target to $86.<br />
&#x2A; An analyst from Benchmark downgraded its action to Sell with a price target of $57.<br />
&#x2A; Consistent in their evaluation, an analyst from Oppenheimer keeps a Outperform rating on Trade Desk with a target price of $135. </p>
<p>Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Trade Desk options trades with real-time alerts from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.</p>


Unpacking the Latest Options Trading Trends in Trade Desk

<p>Investors with a lot of money to spend have taken a bearish stance on <strong>Nike</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NKE#NYSE">NKE</a>).</p>
<p>And retail traders should know.</p>
<p>We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.</p>
<p>Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with NKE, it often means somebody knows something is about to happen.</p>
<p>So how do we know what these investors just did? </p>
<p>Today, <a href="https://pro.benzinga.com/?utm_source=insights">Benzinga</a>'s options scanner spotted 25 uncommon options trades for Nike.</p>
<p>This isn't normal.</p>
<p>The overall sentiment of these big-money traders is split between 44% bullish and 52%, bearish.</p>
<p>Out of all of the special options we uncovered, 16 are puts, for a total amount of $888,906, and 9 are calls, for a total amount of $375,233.</p>
<h3>Projected Price Targets</h3>
<p>After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $60.0 and $95.0 for Nike, spanning the last three months.</p>
<h3>Volume &amp; Open Interest Trends</h3>
<p>Examining the volume and open interest provides crucial insights into stock research. This information is key in gauging liquidity and interest levels for Nike's options at certain strike prices. Below, we present a snapshot of the trends in volume and open interest for calls and puts across Nike's significant trades, within a strike price range of $60.0 to $95.0, over the past month.</p>
<h3>Nike Option Volume And Open Interest Over Last 30 Days</h3>
<p><img src="https://www.benzinga.com/files/images/story/2024/1731687423_0.png" alt="Options Call Chart" /></p>
<h3>Largest Options Trades Observed:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th><strong>Open Interest</strong></th>
<th><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>NKE</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>12/20/24</td>
<td>$2.59</td>
<td>$2.53</td>
<td>$2.53</td>
<td>$75.00</td>
<td>$126.5K</td>
<td>16.5K</td>
<td>526</td>
</tr>
<tr>
<td>NKE</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>12/20/24</td>
<td>$2.53</td>
<td>$2.46</td>
<td>$2.51</td>
<td>$75.00</td>
<td>$125.2K</td>
<td>16.5K</td>
<td>1.0K</td>
</tr>
<tr>
<td>NKE</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>09/19/25</td>
<td>$3.35</td>
<td>$3.25</td>
<td>$3.35</td>
<td>$95.00</td>
<td>$82.7K</td>
<td>1.8K</td>
<td>1</td>
</tr>
<tr>
<td>NKE</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/17/25</td>
<td>$6.1</td>
<td>$6.0</td>
<td>$6.1</td>
<td>$80.00</td>
<td>$67.7K</td>
<td>12.0K</td>
<td>222</td>
</tr>
<tr>
<td>NKE</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/17/25</td>
<td>$6.1</td>
<td>$6.0</td>
<td>$6.08</td>
<td>$80.00</td>
<td>$67.0K</td>
<td>12.0K</td>
<td>111</td>
</tr>
</tbody>
</table>
</p>
<h3>About Nike</h3>
<p>Nike is the largest athletic footwear and apparel brand in the world. Key categories include basketball, running, and football (soccer). Footwear generates about two thirds of its sales. Its brands include Nike, Jordan (premium athletic footwear and clothing), and Converse (casual footwear). Nike sells products worldwide through company-owned stores, franchised stores, and third-party retailers. The firm also operates e-commerce platforms in more than 40 countries. Nearly all its production is outsourced to contract manufacturers in more than 30 countries. Nike was founded in 1964 and is based in Beaverton, Oregon.</p>
<p>Following our analysis of the options activities associated with Nike, we pivot to a closer look at the company's own performance.</p>
<h3>Where Is Nike Standing Right Now?</h3>
<ul>
<li>With a volume of 3,359,657, the price of NKE is up 0.86% at $76.33. </li>
<li>RSI indicators hint that the underlying stock is currently neutral between overbought and oversold.</li>
<li>Next earnings are expected to be released in 34 days.</li>
</ul>
<h3>What Analysts Are Saying About Nike</h3>
<p>1 market experts have recently issued ratings for this stock, with a consensus target price of $80.0.</p>
<p><strong>Unusual Options Activity Detected: Smart Money on the Move</strong></p>
<p>Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;utm_source=benzinga-insights"><strong>Click here for access</strong></a>.<br />
&#x2A; Consistent in their evaluation, an analyst from RBC Capital keeps a Sector Perform rating on Nike with a target price of $80. </p>
<p>Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.</p>
<p>If you want to stay updated on the latest options trades for Nike, <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> gives you real-time options trades alerts.</p>


Behind the Scenes of Nike's Latest Options Trends

<p><strong>Visa Inc</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/V#NYSE">V</a>) stock has climbed following <strong>Donald Trump's</strong> <a href="https://www.benzinga.com/economics/macro-economic-events/24/11/41772701/trumps-historic-return-7-ways-his-second-term-could-impact-the-us-economy">presidential election win</a>, driven by expectations of economic policies that could stimulate consumer spending and benefit payment processors like Visa.</p>
<p>Trump's proposal to extend and expand tax cuts is likely to increase disposable income for households and encourage corporate investment, leading to a surge in transaction volumes—Visa's primary revenue source.</p>
<p><strong>What Else:</strong> Additionally, Trump's deregulatory agenda could benefit Visa by reducing compliance costs in the financial sector, allowing the company to invest more aggressively in innovation. </p>
<p>This could accelerate Visa's development of digital payment technologies, enhance its global network, and foster partnerships with emerging fintech companies. Visa is well-positioned to capitalize on this growth as digital transactions continue to replace cash worldwide.</p>
<p>Trump's focus on economic expansion through infrastructure spending and trade reforms could further bolster Visa's business segment by increasing corporate transactions and cross-border payment activity. </p>
<p>Potential inflationary pressures under Trump's policies may also indirectly benefit Visa, as higher transaction values generate increased processing fees.</p>
<p><strong>Read Also: <a href="https://www.benzinga.com/news/earnings/24/11/42006281/alibaba-q2-earnings-revenue-beats-forecast-cloud-and-international-sales-shine-free-cash-flow-falls-amid-strategic-investments">Alibaba Q2 Earnings: Revenue Beats Forecast, Cloud and International Sales Shine, Free Cash Flow Falls Amid Strategic Investments</a></strong></p>
<h2 class="wp-block-heading">Is V A Good Stock To Buy?</h2>
<p>An investor can make a few decisions when deciding whether a stock is a good buy. In addition to valuation metrics and price action which you can find on Benzinga's quote pages  &#8211; like <a href="https://www.benzinga.com/quote/V">Visa</a>&#8216;s page for example &#8211; there are factors like whether or not a company pays a dividend or buys a large portion of its stock each quarter.</p>
<p>These are known as capital allocation programs. Visa does pay a dividend, which yields 0.78% per year as of the closing price on Nov. 15, 2024. Feel free to search Benzinga's <a href="https://www.benzinga.com/calendars/dividends">dividend calendar</a> for the next company that is due to pay a dividend and determine what kind of yield you can earn for holding a share of the company.</p>
<p>Buyback programs are obviously different and highly variable. A company can approve a buyback program and purchase shares as it sees fit over the course of time in which the buyback was authorized. Looking through the latest news on <a href="https://www.benzinga.com/quote/V">Visa</a> will often yield whether or not the company has approved a buyback program recently. Buyback programs usually serve as a support for share prices, serving as a backstop for demand.</p>
<p>According to data from&nbsp;<a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>, V has a 52-week high of $312.44 and a 52-week low of $245.60.</p>


Why Visa Stock Hit A New 52-Week High This Week

The Oncology Institute shares are trading lower. The stock may be moving on continued weakness following worse-than-expected Q3 financial results reported on Wednesday.

<p>Nvidia CEO Jensen Huang and SoftBank&#8217;s Masayoshi Son recently shared a few laughs and some bittersweet memories at the AI Summit in Tokyo. At the center of their banter? SoftBank&#8217;s former role as Nvidia&#8217;s largest shareholder – and how they decided to let that golden opportunity slip away.</p>
<p><figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"><br />
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true"><p lang="en" dir="ltr">Billionaires Jensen Huang and Masayoshi Son joke about how SoftBank was once Nvidia&#39;s largest shareholder — before dumping its stake. <br /><br />The two are now joining forces on an AI supercomputer <a href="https://t.co/UjUIVaCinN">https://t.co/UjUIVaCinN</a> <a href="https://t.co/rfd1p1yKB0">pic.twitter.com/rfd1p1yKB0</a></p>
<p>&mdash; Bloomberg (@business) <a href="https://twitter.com/business/status/1856563439331618846?ref_src=twsrc%5Etfw">November 13, 2024</a></p></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
<p></p></figure></p>
<p><strong>Don't Miss:</strong></p>
<ul>
<li><strong>This Adobe-backed AI marketing startup went from a $5 to $85 million valuation working with brands like L'Oréal, Hasbro, and Sweetgreen in just three years –<a href="https://www.benzinga.com/money/rad-ai"><strong> </strong><strong>here's how there's a limited time opportunity to invest at $1,000 for only $0.50/share before closing date.</strong></a></strong></li>
<li><strong>The global games market is projected to generate $272B by the end of the year —<a href="https://www.benzinga.com/money/gameflip"><strong> </strong><strong>for $0.55/share, this VC-backed startup with a 7M+ userbase gives investors easy access to this asset market.</strong></a></strong></li>
</ul>
<p>In 2019, SoftBank (OTC:<a class="ticker" href="https://www.benzinga.com/stock/SFTBF#OTC">SFTBF</a>) sold all of its Nvidia (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) shares, which comprised about 4.9% of the company. It seemed like a solid move back then: they had invested around $700 million and ended up making $3.3 billion from the sale. But now, Son admits the decision wasn&#8217;t exactly a home run. Today, <a href="https://www.benzinga.com/general/24/06/39489510/the-150-billion-opportunity-softbank-lost-by-selling-nvidia-shares-too-soon">those shares would be worth over $150 billion</a>.</p>
<p>During their talk, Huang jokingly said, &#8220;We can cry together,&#8221; hugging Son on stage as they remembered what might have been. Son, not missing a beat, added that he had to &#8220;tearfully&#8221; sell those shares. Huang even shared that Son once offered him financial backing to buy Nvidia outright – something he now wishes he'd taken. &#8220;That was a great idea,&#8221; Huang said, with a hint of regret.</p>
<p><strong>Trending: ‘Scrolling to UBI': Deloitte's #1 fastest-growing software company allows users to earn money on their phones –<a href="https://www.benzinga.com/money/mode-mobile-2"><strong> </strong><strong>invest today with $1,000 for just $0.25/share</strong></a></strong></p>
<p>Huang praised Son for being a visionary who has consistently backed winning innovators like Bill Gates, Jerry Yang and Steve Jobs. Son has a talent for recognizing big opportunities and helping establish major tech moments, from bringing Gates and Jobs to Japan to making Alibaba&#8217;s success possible in China. Yet, even with all those successes, the missed Nvidia chance still stings.</p>
<p>Today, <a href="https://www.benzinga.com/quote/NVDA">Nvidia is worth $3.6 trillion</a> and is the world&#8217;s most valuable company, ahead of tech giants like Apple and Microsoft. Its value has skyrocketed thanks to the AI boom, with its chips playing a crucial role in powering AI technologies across the globe. Nvidia&#8217;s stock has surged 2,768% in the last five years, putting <a href="https://www.benzinga.com/startups/24/11/41882908/640416">Jensen Huang&#8217;s net worth</a> at a staggering $127 billion.</p>
<p><strong>See Also: Maker of the $60,000 foldable home has 3 factory buildings, 600+ houses built, and big plans to solve housing —<a href="https://www.benzinga.com/money/boxabl"><strong> </strong><strong>you can become an investor for $0.80 per share today.</strong></a></strong></p>
<p>SoftBank, meanwhile, remains heavily invested in the future of AI. Son has made it clear that he&#8217;s not done yet. He recently mentioned that his true purpose might be to <a href="https://www.benzinga.com/news/24/10/41181374/softbanks-masayoshi-son-predicts-artificial-superintelligence-within-a-decade-after-testing-openais">bring about artificial superintelligence (ASI) – </a>a form of AI that could be 10,000 times smarter than humans. His belief in the power of AI and its ability to solve global problems, from diseases to natural disasters, keeps driving him forward.</p>
<p>Despite the missed opportunity with Nvidia, SoftBank is moving ahead at full throttle. Son and Huang recently <a href="https://www.benzinga.com/news/global/24/11/41929194/nvidia-and-softbank-to-build-japans-top-ai-supercomputer-on-blackwell-platform-jensen-huang-says-tokyo-is-leaping-into-the-ai-industrial-revolution">announced a partnership</a> to build Japan&#8217;s most powerful AI supercomputer using Nvidia&#8217;s latest Blackwell chips. The goal? To establish Japan as a major player in AI, with applications that could transform industries like telecommunications, health care and transportation.</p>
<p><strong>Read Next:</strong></p>
<ul>
<li><strong>With over 7.8K investors including Meta, Google, And Amazon Execs — this AI Startup's valuation has skyrocketed from $5 million to $85 million in just three years. <a href="https://www.benzinga.com/money/rad-ai"><strong>Be an early investor with just $1,000 for only $0.50/share today before the offer closes in 2 weeks.</strong></a></strong></li>
<li><strong>Deloitte's fastest-growing software company partners with Amazon, Walmart &amp; Target –<a href="https://www.benzinga.com/money/mode-mobile-2"><strong> </strong><strong>You can still get 4,000 of its pre-IPO shares for just $1,000</strong></a></strong></li>
</ul>


Startups

NVDA

SFTBF

Must See: Billionaires Jensen Huang And Masayoshi Son Joke About SoftBank's Past As Nvidia's Largest Shareholder – Before Dumping Its Stake

<p>RBC Capital  analyst Arthur Nagorny   maintains Mattr (TSX:<a class="ticker" href="https://www.benzinga.com/stock/MATR#TSX">MATR</a>) with a Outperform and lowers the price target from C$20 to C$18.</p>


TSX:MATR

RBC Capital Maintains Outperform on Mattr, Lowers Price Target to C$18

<p><strong>Mullen Automotive, Inc. </strong>(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MULN#NASDAQ">MULN</a>) shares are trading lower on Friday. The company partnered with <strong>National Auto Fleet Group</strong> (NAFG) to sell its all-electric Class 4 Bollinger B4 commercial <a href="https://www.benzinga.com/pressreleases/24/11/g42008604/mullen-subsidiary-bollinger-motors-partners-with-national-auto-fleet-group-for-government-fleet-ve" target="_blank" rel="noreferrer noopener">trucks to government agencies</a>.</p>
<p>The Bollinger B4 Chassis Cab, a fully electric Class 4 commercial truck, offers a range of 185 miles and a payload capacity of 7,394 pounds.</p>
<p>The Bollinger B4 is ideal for commercial, government, and municipal fleets seeking a versatile, high-performance truck for a variety of tasks.</p>
<p>Bollinger CRO <strong>Jim Connelly</strong> said, &#8220;Government agencies and municipalities are often early adopters for electrification and electric vehicle fleets. We look forward to partnering with NAFG, and their history of bringing innovative products and solutions to this important segment.&#8221;</p>
<p>Mullen announced its Class 1 EV cargo van, the Mullen ONE, is available for rent on Turo, a vehicle-sharing marketplace. The effort is in collaboration with Parasol Strategic Solutions,<a href="https://www.benzinga.com/trading-ideas/movers/24/11/41913722/whats-going-on-with-mullen-automotive-stock-tuesday-2" target="_blank" rel="noreferrer noopener"> a high-level Turo host based in Florida</a>.</p>
<p>Last month, Bollinger Motors completed its first West Coast delivery of 2025 <a href="https://www.benzinga.com/markets/equities/24/10/41630662/mullens-bollinger-motors-marks-milestone-with-500-thousand-west-coast-ev-truck-delivery" target="_blank" rel="noreferrer noopener">Bollinger B4 trucks worth ~$500K</a>.</p>
<p>Also, Bollinger Motors completed its first customer delivery of the 2025&nbsp;Bollinger B4 Chassis Cab, generating $800,000 in revenue for the <a target="_blank" href="https://www.benzinga.com/markets/equities/24/10/41166786/whats-going-on-with-mullen-automotive-stock-thursday" rel="noreferrer noopener">original equipment manufacturer</a>.</p>
<p><strong>Price Action</strong>: Mullen Automotive shares are down 9.28% at $3.13, at the last check Friday.</p>
<p><strong>Read Next:</strong></p>
<ul>
<li><strong><a href="https://www.benzinga.com//node/42011035" target="_blank" rel="noreferrer noopener">Just Before Biden&#8217;s Term Ends, Taiwan Semiconductor Lands $6.6 Billion in US Funding to Build Advanced Chip Plants</a></strong></li>
</ul>
<p><em>Image: Courtesy of Mullen Automotive</em></p>


Equities

Contracts

Small Cap

Movers

MULN

Mullen Drives Into Government Sector With Electric Bollinger B4 Trucks

<p>BMO Capital  analyst Stephen MacLeod   reiterates CCL Industries (TSX:<a class="ticker" href="https://www.benzinga.com/stock/CCL#TSX">CCL</a>) with a Outperform and raises the price target from C$90 to C$93.</p>


Reiteration

TSX:CCL

TSX:CCL/B

BMO Capital Reiterates Outperform on CCL Industries, Raises Price Target to C$93

<p>RBC Capital  analyst Douglas Miehm   maintains Medical Facilities (TSX:<a class="ticker" href="https://www.benzinga.com/stock/DR#TSX">DR</a>) with a Sector Perform and raises the price target from C$16 to C$17.</p>


TSX:DR

RBC Capital Maintains Sector Perform on Medical Facilities, Raises Price Target to C$17

<p>BMO Capital  analyst Sohrab Movahedi   reiterates Brookfield (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BN#NYSE">BN</a>) with a Outperform and raises the price target from $50 to $62.</p>


BMO Capital Reiterates Outperform on Brookfield, Raises Price Target to $62

ASML

ASML Holding shares are trading lower after Third Point disclosed in a 13F filing that it exited its position in the company.

UMAC

Unusual Machines shares are trading lower after the company reported a year-over-year decline in Q3 EPS results.

<p>RBC Capital  analyst Maurice Choy   reiterates Keyera (TSX:<a class="ticker" href="https://www.benzinga.com/stock/KEY#TSX">KEY</a>) with a Outperform and maintains C$45 price target.</p>


TSX:KEY

RBC Capital Reiterates Outperform on Keyera, Maintains C$45 Price Target

<p><strong>Wells Fargo &amp; Company</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WFC#NYSE">WFC</a>) shares are trading <a target="_blank" href="https://www.benzinga.com/movers" rel="noreferrer noopener">mostly flat on Friday.</a></p>
<p>According to&nbsp;<a target="_blank" href="https://pro.benzinga.com/?gspk=YWRhbWVja2VydDUzMzY&amp;gsxid=zBMR4PKmcgBw" rel="noreferrer noopener">Benzinga Pro</a>, WFC stock has gained 71% in the past year. Investors can gain exposure to the stock via&nbsp;Invesco KBW Bank ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KBWB#NASDAQ">KBWB</a>) and&nbsp;First Trust Nasdaq Bank ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FTXO#NASDAQ">FTXO</a>).</p>
<p>Recently, the stock has seen marked strength following&nbsp;<strong>Donald Trump&#8217;s</strong>&nbsp;<a target="_blank" href="https://www.benzinga.com/economics/macro-economic-events/24/11/41772701/trumps-historic-return-7-ways-his-second-term-could-impact-the-us-economy" rel="noreferrer noopener">presidential election win</a>, as investors anticipate that his administration&#8217;s economic policies could create a<a target="_blank" href="https://www.benzinga.com/news/24/11/41977586/whats-going-on-with-wells-fargo-wfc-shares" rel="noreferrer noopener"> favorable climate for major banks.</a></p>
<p>Trump&#8217;s tax agenda, which includes potential expansions to the&nbsp;<strong>2017 Tax Cuts and Jobs Act</strong>, could lower corporate tax rates further, directly boosting Wells Fargo&#8217;s earnings.</p>
<p>Today, Wells Fargo declared quarterly dividends on several of its preferred stock series,<a target="_blank" href="https://www.benzinga.com/pressreleases/24/11/b42006575/wells-fargo-company-declares-cash-dividends-on-preferred-stock" rel="noreferrer noopener"> payable on December 16, 2024.</a></p>
<p>The company declared a quarterly dividend of $18.75 per share on its 7.50% noncumulative perpetual convertible Class A preferred stock, Series L. The stock has a liquidation preference of $1,000 per share. It trades on the New York Stock Exchange under the symbol &#8220;WFCPrL&#8221;. The dividend will be paid on December 16, 2024.</p>
<p><strong>Also Read: <a target="_blank" href="https://www.benzinga.com/news/24/11/42006982/activist-investor-nelson-peltz-says-he-was-a-matchmaker-for-elon-musk-with-donald-trump" rel="noreferrer noopener">Activist Investor Nelson Peltz Says He Was &#8216;A Matchmaker&#8217; For Elon Musk With Donald Trump</a></strong></p>
<p>For Series Y, the dividend is $0.35156 per depositary share, with a liquidation preference of $25,000 per share.</p>
<p>For Series Z, the dividend is $0.29688 per depositary share, with a liquidation preference of $25,000 per share.</p>
<p>For Series AA, the dividend is $0.29375 per depositary share, with a liquidation preference of $25,000 per share.</p>
<p>For Series CC, the dividend is $0.27344 per depositary share, and for Series DD, it&#8217;s $0.26563 per depositary share, both with a liquidation preference of $25,000 per share.</p>
<p>Wells Fargo said shareholders must be on record by the close of business on November 29, 2024, to qualify for the dividend.</p>
<p><strong>Price Action: </strong>WFC shares are trading higher by 0.81% to $73.39 at last check Friday.</p>
<p><em>Image via Shutterstock</em></p>
<p><strong>Read Next:</strong></p>
<ul>
<li><strong><a href="https://www.benzinga.com/news/24/11/41961033/gene-munster-says-elon-musks-doge-efficiency-plans-should-not-be-underestimated-but-warns-itll-likely-take-many-years-to-achieve-2-trillion-in-government-spending?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Gene Munster Says Elon Musk&#8217;s DOGE Efficiency Plans Should Not Be Underestimated, But Warns &#8216;It&#8217;ll Likely Take Many Years&#8217; To Achieve $2 Trillion In Government Spending Cuts</a></strong></li>
</ul>


Dividends

General

FTXO

KBWB

Wells Fargo Declares Dividends On Six Series Of Preferred Stock: Details

<p>UBS  analyst Shneur Gershuni   maintains Western Midstream (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WES#NYSE">WES</a>) with a Neutral and lowers the price target from $40 to $37.</p>


UBS Maintains Neutral on Western Midstream, Lowers Price Target to $37

<p><a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a></p>
<p>Given that cannabis legalization is considered a growth trend, you may assume that there are few (if any) undervalued <a href="https://investorplace.com/industries/healthcare/cannabis/">cannabis stocks</a>. However, whether we&rsquo;re talking about undervalued in the traditional sense of the term, or undervalued using other metrics, there are plenty of names in the space that fit within this category.</p>



<p>There are companies either directly in the cannabis space, or in adjacent industries, that trade at low price-to-earnings multiples, or at a discount to book value. In addition, there are cannabis stocks to buy based upon the fact that they are undervalued relative to future potential.</p>



<p>What makes these types of cannabis stocks appealing is the fact that, given their under-appreciation by the market, small positive developments could drive big gains, given the potential for shares to surge both on improving fundamentals and price discovery.</p>



<p>This could especially prove to be the case if and when the U.S. federal marijuana laws are relaxed/reformed. With this in mind, let&rsquo;s dive in and take a look at the seven most undervalued cannabis stocks currently out there.</p>



<h2>Green Thumb Industries (GTBIF)</h2>


<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2019/07/aurora-cannabis-stock-1-1-300x169.jpg" alt="cannabis stocks"><div>Source: Shutterstock</div></div>


<p><strong>Green Thumb Industries</strong> (OTCMKTS:<a href="https://investorplace.com/stock-quotes/gtbif-stock-quote/"><strong>GTBIF</strong></a>) is a leading multi-state operator. MSOs are companies that own and operate regulated cannabis operations across multiple U.S. states.  On a P/E and price-to-book basis, this cannabis purveyor does not appear undervalued.</p>



<p>GTBIF stock currently has a forward earnings multiple of 55.8, and trades at a 52% premium to book value. However, as analysts at Zuanic &amp; Associates (a cannabis stock research firm) argued last month, this <a href="https://seekingalpha.com/news/4030722-zuanic-bullish-on-cannabis-stocks-verano-marimed-planet-13-green-thumb">&ldquo;blue chip among the larger MSOs,&rdquo;</a> strong growth potential, irrespective of whenever federal marijuana law reforms ever happen.</p>



<p>Green Thumb shares have performed solidly in 2023, surging by nearly 20%. A <a href="https://www.marketwatch.com/story/curaleaf-and-canopy-growth-miss-q3-analyst-marks-while-ascend-wellness-beats-forecasts-d64ecb04">revenue and earning beat</a> last quarter may suggest strong operating performance will continue in the quarters ahead. The company&rsquo;s existing large presence would also likely give it a big first mover advantage if cannabis became fully legal on the U.S. federal level. </p>



<h2>Innovative Industrial Properties (IIPR)</h2>


<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2019/07/aurora-cannabis-stock-7-300x169.jpg" alt="A close-up shot of a marijuana growhouse. cannabis trends"><div>Source: Shutterstock</div></div>


<p><strong>Innovative Industrial Properties</strong> (NYSE:<a href="https://investorplace.com/stock-quotes/iipr-stock-quote/"><strong>IIPR</strong></a>) is not directly in the cannabis business. Rather, this real estate investment trust  owns and leases out commercial property to state-licensed cannabis operators.</p>



<p>Using traditional metrics, IIPR stock is one of the undervalued cannabis stocks. This REIT trades at a price-to-funds from operations ratio of just 10.7, a discounted multiple compared to other industrial REITs. Admittedly, industry risks help to explain this valuation discrepancy.</p>



<p>However, if the Federal Reserve pivots on interest rates next year, IIPR, like other REITs, is likely to benefit from a re-expansion of its multiple. Revenue (<a href="https://www.businesswire.com/news/home/20231101542273/en/Innovative-Industrial-Properties-Reports-Third-Quarter-2023-Results">up nearly 10% last quarter</a>) and FFO (up 7.5% last quarter) also continue to grow at a steady clip. Potential upside from growth and lower interest rates, coupled with IIPR&rsquo;s 8.13% dividend, could be the recipe for some strong long-term total returns.</p>



<h2>Cannara Biotech (LOVFF)</h2>


<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2019/07/aurora-cannabis-stock-5-300x169.jpg" alt="aurora stock"><div>Source: Shutterstock</div></div>


<p><strong>Cannara Biotech</strong> (OTCMKTS:<a href="https://investorplace.com/stock-quotes/lovff-stock-quote/"><strong>LOVFF</strong></a>) is a cannabis stock that I&rsquo;ve previously noted as being <a href="https://investorplace.com/2023/08/7-smoking-hot-420-stocks-to-buy-in-2023/">undervalued and under-the-radar</a>. Shares in this Canada-based vertically-integrated cannabis firm trade for only 11.4 times trailing twelve month earnings. </p>



<p>LOVFF stock sports this low multiple, although the company&rsquo;s revenue increased by <a href="https://www.otcmarkets.com/otcapi/company/financial-report/389000/content">93%</a> last fiscal year (ending August 2023), with net income surging threefold during this same time frame. That&rsquo;s not to say, of course, that the current fiscal year will bring similar growth.</p>



<p>But even if Cannara&rsquo;s growth decelerates from here, greater awareness of this low-priced pot stock could result in outsized gains for shares. Keep in mind that Cannara is relatively less liquid than other names in the space. That may present challenges if you&rsquo;re looking to enter/exit a position. However, if you are aware of the risks, it&rsquo;s one of the top cannabis stocks to consider.</p>



<h2>WM Technology (MAPS)</h2>


<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2019/07/aurora-cannabis-stock-8-300x169.jpg" alt="Forget a 1-for-12 Split, Aurora Stock May as Well Go for 200"><div>Source: Shutterstock</div></div>


<p><strong>WM Technology</strong> (NASDAQ:<a href="https://investorplace.com/stock-quotes/maps-stock-quote/"><strong>MAPS</strong></a>) is one of the more unique cannabis stocks. This company&rsquo;s shares make it a SaaS stock and a cannabis stock play. </p>



<p>After experiencing a big run-up in growth from the late-2010s through 2022, WM Technology has experienced a bit of a growth slump.</p>



<p>Yet despite entering a near-term rough patch, as <em>InvestorPlace&rsquo;s</em> Jeremy Flint pointed out in October, long-term growth potential with MAPS stock <a href="https://investorplace.com/2023/10/the-diy-cannabis-portfolio-7-stocks-from-seed-to-stem/">remains high</a>. According to Flint, the cannabis industry is expected to keep growing at a 25% annualized clip through the start of the next decade. </p>



<p>Such growth could be even stronger if federal cannabis law reforms arrive far sooner than currently anticipated. That&rsquo;s not all. <a href="https://seekingalpha.com/article/4649517-wm-technology-inc-maps-q3-2023-earnings-call-transcript">Operational strategy changes</a> discussed on WM&rsquo;s most recent earnings conference call could result in better-than-expected results in the quarters ahead. </p>



<h2>Marimed (MRMD)</h2>


<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2019/07/Marijuana1600-300x169.jpg" alt="Image of marijuana alongside three joints"><div>Source: Shutterstock</div></div>


<p><strong>Marimed</strong> (OTCMKTS:<a href="https://investorplace.com/stock-quotes/mrmd-stock-quote/"><strong>MRMD</strong></a>) is another cannabis stock that I&rsquo;ve previously noted as being undervalued in the traditional sense. However, since last discussing this particular MSO, the company has gone from reporting positive earnings to reporting net quarterly losses.</p>



<p>So, why do I consider it still one of the undervalued names in the space? As Zuanic &amp; Associates noted in the aforementioned research report, Marimed&rsquo;s swing to quarterly losses has to do with its ramping up of growth-related capital expenditures.</p>



<p>By keeping its foot on the growth gas pedal, Marimed could quickly scale into one of the top MSOs. Once the company is ready to take its foot off the pedal, this could result in a dramatic increase in profits. This in turn could result in a big jump for MRMD shares. As also noted before, Marimed could be <a href="https://investorplace.com/2023/06/7-otc-stocks-to-buy-with-boatloads-of-potential/">an ideal acquisition candidate</a>, whenever federal cannabis laws finally change.</p>



<h2>Newlake Capital Partners (NLCP)</h2>


<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2019/07/aurora-cannabis-stock-9-300x169.jpg" alt="A close-up shot of hands holding a grinder with cannabis buds in the background representing aurora stock."><div>Source: Shutterstock</div></div>


<p>Just like IIPR, <strong>Newlake Capital Partners</strong> (OTCMKTS:<a href="https://investorplace.com/stock-quotes/nlcp-stock-quote/"><strong>NLCP</strong></a>) is a cannabis REIT, owning and leasing out space to state-licensed cannabis producers. If IIPR is one of the undervalued cannabis stocks, one could say that Newlake is one of the deep value cannabis stocks.</p>



<p>Yes, NLCP stock trades at a discount, because of perceptions that it is a riskier cannabis REIT. However, as a <em>Seeking Alpha</em> commentator recently argued, this valuation discrepancy <a href="https://seekingalpha.com/article/4653246-newlake-capital-partners-one-safest-double-digit-dividend-reits">may more than cover the increased risks</a>.</p>



<p>Based on valuation metrics, it&rsquo;s easy to agree with this commentator&rsquo;s take. NLCP trades at a P/FFO ratio of 7.9, well below that of IIPR. This REIT also trades at a 30% discount to book value, and sports a double-digit dividend yield (11.22%). The reporting of &ldquo;less bad&rdquo; results, lower interest rates, and cannabis law reforms are all catalysts that could drive an eventual big comeback for NLCP.</p>



<h2>Turning Point Brands (TPB)</h2>


<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2019/07/aurora-cannabis-stock-6-300x169.jpg" alt="cannabis stocks, With America Turning Green Things Only Can Get Better for Aurora Stock"><div>Source: Shutterstock</div></div>


<p>Back in April, I called <strong>Turning Point Brands</strong> (NYSE:<a href="https://investorplace.com/stock-quotes/tpb-stock-quote/"><strong>TPB</strong></a>) <a href="https://investorplace.com/2023/04/the-7-best-cannabis-stocks-to-buy-for-april-2023/">one of the top cannabis stocks</a>. Even as TPB has delivered a mixed price performance since then, I still consider it one of the cannabis stocks to buy. This is not a cannabis pure play.</p>



<p>Turning Point is primarily a tobacco company, with Stoker&rsquo;s smokeless tobacco its most prominent brand. However, as the U.S. distributor/marketer of Zig Zag rolling papers, it has high exposure (pun intended) to the cannabis sector. Zig Zag sales <a href="https://www.turningpointbrands.com/investor-relations/news/news-details/2023/Turning-Point-Brands-Announces-Third-Quarter-2023-Results-and-Closing-of-New-ABL-Facility/default.aspx">have entered a slump recently</a>, and the main play with TPB stock now has more to do with the continued growth of Stoker&rsquo;s.</p>



<p>Still, if Turning Points pulls off a turnaround of the Zig Zag segment, low-priced TPB (trading for just 8.8 times earnings) could surge substantially, thanks to both profitability growth and multiple expansion.</p>



<p><em>On the date of publication, Thomas Niel&nbsp;did not hold (either directly or indirectly) any positions in the securities mentioned in this article.&nbsp;The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.</em></p>
<div><p>Thomas Niel, contributor for InvestorPlace.com, has been writing single-stock analysis for web-based publications since 2016.</p></div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT771234">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT771244">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/05/secret-income-blueprint-of-the-one-percent/?cid=MKT730394&amp;eid=MKT771242">The Rich Use This Income Secret (NOT Dividends) Far More Than Regular Investors</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	
<p>The post <a href="https://investorplace.com/2023/12/the-7-most-undervalued-cannabis-stocks-to-buy-in-december/">The 7 Most Undervalued Cannabis Stocks to Buy in December</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.</p>

The 7 Most Undervalued Cannabis Stocks to Buy in December

Cannara Biotech, Inc. (TSE:LOVE) has released an update. Cannara Biotech Inc. has reported a significant increase in financial results for Q2 2024,...

Cannara Biotech Boasts Strong Q2 Growth

Cannara Biotech reports Q2 results

Cannara Biotech (TSE:LOVE) has released an update. Cannara Biotech Inc. has reported a significant increase in net revenues to $19.5 million for Q3...

Cannara Biotech's Revenue Soars in Q3 2024

Cannara Biotech GAAP EPS of C$0.02, revenue of C$19.5M

Cannara Biotech (TSE:LOVE) has released an update. Cannara Biotech Inc. has reached a new pinnacle by achieving a record national market share of 3...

Comments

Cannara Biotech

Cannara Biotech (LOVFF) Opzioni

No option chain data available. Please try again later

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO